Drugs / BGC20-0582
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00528021 Comparator | Aug 2007 → May 2008 | Pediculus humanus capitis infestation | Boston Scientific Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BGC20-0582 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00528021 ↗ |
| Route | Topical | “with either placebo or 2.5% BGC20-0582 topically” NCT00528021 ↗ |